Mostrando 5 resultados de: 5
Publisher
ChemMedChem(3)
2007 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2007, Technical Proceedings(1)
ACS Nano(1)
Área temáticas
Farmacología y terapéutica(5)
Ingeniería y operaciones afines(2)
Enfermedades(1)
Ingeniería civil(1)
Medicina y salud(1)
Origen
scopus(5)
Co-delivery of hydrophobic and hydrophilic drugsfrom nanoparticle-aptamer bioconjugates
ArticleAbstract: (Figure Presented) Herein we report a novel targeted drug delivery system consisting of nanoparticlePalabras claves:Antitumor agents, conjugation, Dual drug delivery, Nanoparticles, Targeted therapyAutores:Bagalkot V., Basto P.A., Farokhzad O.C., Frank Alexis, Gu F.X., Jon S., Langer R.S., Radovic-Moreno A.F., Zhang L.Fuentes:scopusHER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy
ArticleAbstract: (Figure Presented) Affibodies are a class of polypeptide ligand that are potential candidates for tiPalabras claves:Affibodies, Antitumor agents, Nanoparticles, PLA-PEG copolymers, Targeted therapyAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Levy-Nissenbaum E., Marein S.L., Molnar L.K., Pridgen E.M., Radovic-Moreno A.F., Wang A.Z., Westerhof K., Zhang L.Fuentes:scopusSelf-assembled lipid-polymer hybrid nanoparticles: A robust drug delivery platform
ArticleAbstract: We report the engineering of a novel lipid-polymer hybrid nanoparticle (NP) as a robust drug deliverPalabras claves:drug delivery, Liposome, Nanoprecipitation, Polymeric nanoparticle, self-assemblyAutores:Chan J.M., Farokhzad O.C., Frank Alexis, Gu F.X., Langer R.S., Radovic-Moreno A.F., Rhee J.W., Wang A.Z., Zhang L.Fuentes:scopusSuperparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy
ArticleAbstract: (Chemical Equation Presented) Multifunctional superparamagnetic iron oxide nanoparticles: Herein wePalabras claves:doxorubicin, Nanoparticles, Superparamagnetic, TCL-SPIONAutores:Bagalkot V., Bander N.H., Cima M.J., Farokhzad O.C., Frank Alexis, Gu F.X., Jon S., Kantoff P.W., Langer R.S., Shaikh M., Vasilliou C.C., Wang A.Z., Yuet K., Zhang L.Fuentes:scopusTargeted aptamer-nanoparticles to diminish drug resistance of cancer cells in vitro study
Conference ObjectAbstract: Using prostate cancer as a model, we report the drug release of Docetaxel and doxorubicin from aptamPalabras claves:aptamer, doxorubicin, Poly (D,L-lactic-co-glycolic acid) (PLGA), Prostate cancer, Targeted deliveryAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Langer R.S., Zhang L.Fuentes:scopus